Skip to main content
Premium Trial:

Request an Annual Quote

QED Solutions New CSO Will Oversee Nascent Genomics Tech Division

NEW YORK, Dec. 10 — Genomics expert George F. Steinfels was named chief scientific officer of QED Solutions and general manager of the company's new genomics technology division, QNOME, the firm said on Monday.

 

With expertise in the application of genomic technologies to drug development, Steinfels will seek to improve and expand the company's Qscan dataset, which allows researchers to access drug profiles, monitor adverse drug events, analyze potential interactions, and correlate compounds with known drugs over the Internet. The new QNOME division, by comparison, is designed to use genome technology to help improve drug safety.

 

QED Solutions, of McLean, Va., was founded in 1998, and specializes in products that can be used to improve drug safety both for candidate drugs and approved pharmaceuticals.

 

Steinfels founded the consultant group Genomic Strategies and was previously chief operating officer of the pharmacogenomics business at Quintiles.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.